Navigation Links
Kensey Nash to Participate in the Sidoti Twelfth Annual New York Emerging Growth Institutional Investor Forum Conference
Date:3/11/2008

EXTON, Pa., March 11 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Sidoti Twelfth Annual New York Emerging Growth Institutional Investor Forum at The Grand Hyatt Hotel in New York on Wednesday, March 26, 2008.

Joseph W. Kaufmann, Kensey Nash's President and CEO, will deliver the Company's presentation, beginning at approximately 11:35 a.m. (ET). The presentation materials will be available on the company's website (http://www.kenseynash.com) beginning at 11:35 a.m. (ET) on Wednesday, March 26, 2008.

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily in the endovascular, sports medicine and spine markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also commercialized a series of innovative products through its own direct endovascular sales force. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.


'/>"/>
SOURCE Kensey Nash
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million
2. Kensey Nash Corporation Announces Its Second Quarter 2008 Earnings Release Date and Teleconference
3. Kensey Nash to Present at the 19th Annual Piper Jaffray Health Care Conference
4. Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
5. Kensey Nash Reports First Quarter Fiscal Year 2008 Results
6. Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares
7. Kensey Nash Announces $25 Million Stock Repurchase Program
8. Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
9. Johnson & Johnson to Participate in Lehman Brothers Eleventh Annual Global Healthcare Conference
10. DURECT to Participate in Cowen Annual Healthcare Conference
11. E-Z-GO and Visiprise to Participate in New Product Introduction Event with IndustryWeek
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... The 9th annual meeting of ... (WMIC), will be held in New York City, NY on September 7 – ... congress will highlight and emphasize how imaging reveals a greater understanding of the ...
(Date:2/10/2016)... ... February 10, 2016 , ... Early this week, Team Iconic at ... of Nestlé KITKAT as the first global confectionery brand sourced from 100% sustainable cocoa. ... the quality of their product, through activities that focus on better farming, better lives ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... a full-service health care communications company offering education, research and medical media, ... practitioners and specialists working in infectious diseases. , As the all-inclusive resource ...
(Date:2/10/2016)... ... February 10, 2016 , ... MetLoop CEO Jay ... 2.0 version at the International Roofing Expo in Orlando, Florida on February 17-19. ... most advanced weather technology in the hands of consumers, roofing contractors, manufacturers and ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... (VRI) within Healthcare, recently partnered with Heart City Health Center to ... nearly 23 years, Heart City Health Center has provided the Elkhart community with ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 10, 2016 --> --> This press ... .  --> Japan .  --> A separate press ... With submission, Shire continues to strengthen its presence ... Shire continues to strengthen its presence ... Shire continues to strengthen its presence in ...
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 /PRNewswire/ ... in viral gene therapy manufacturing, and Renova™ Therapeutics, a ... failure and other chronic diseases, have entered into a ... and produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for use ... --> --> This relationship will leverage ...
(Date:2/10/2016)... Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko ... completed, through its indirect wholly-owned subsidiary Laurel Acquisition Inc. ... outstanding shares of common stock of Ocata Therapeutics, Inc. ... "Ocata") for a price of US$8.50 per share net ... the Tender Offer on November 19, 2015, U.S. Eastern ...
Breaking Medicine Technology: